Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$51.07 - $68.26 $3.74 Million - $4.99 Million
-73,138 Reduced 46.65%
83,649 $5.21 Million
Q4 2023

Feb 09, 2024

BUY
$55.6 - $77.89 $3.73 Million - $5.23 Million
67,085 Added 74.79%
156,787 $9.72 Million
Q3 2023

Nov 13, 2023

BUY
$60.27 - $90.75 $2.13 Million - $3.21 Million
35,411 Added 65.22%
89,702 $6.23 Million
Q2 2023

Aug 10, 2023

BUY
$82.41 - $99.65 $2.83 Million - $3.42 Million
34,355 Added 172.33%
54,291 $4.56 Million
Q1 2023

May 09, 2023

BUY
$47.76 - $82.86 $952,143 - $1.65 Million
19,936 New
19,936 $1.65 Million
Q2 2022

Aug 05, 2022

SELL
$55.54 - $72.65 $4.41 Million - $5.77 Million
-79,470 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$24.28 - $56.64 $699,361 - $1.63 Million
-28,804 Reduced 26.6%
79,470 $4.4 Million
Q4 2021

Feb 10, 2022

BUY
$22.54 - $30.44 $116,531 - $157,374
5,170 Added 5.01%
108,274 $3.13 Million
Q3 2021

Nov 12, 2021

BUY
$24.23 - $28.59 $2.13 Million - $2.51 Million
87,764 Added 572.13%
103,104 $2.65 Million
Q2 2021

Aug 12, 2021

BUY
$19.51 - $27.64 $299,283 - $423,997
15,340 New
15,340 $424,000
Q2 2020

Aug 13, 2020

SELL
$10.34 - $15.51 $1.3 Million - $1.96 Million
-126,083 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$9.11 - $20.05 $88,412 - $194,585
9,705 Added 8.34%
126,083 $1.61 Million
Q4 2019

Feb 12, 2020

SELL
$18.47 - $24.03 $649,220 - $844,654
-35,150 Reduced 23.2%
116,378 $2.39 Million
Q3 2019

Nov 13, 2019

SELL
$21.01 - $28.94 $1.08 Million - $1.49 Million
-51,375 Reduced 25.32%
151,528 $3.8 Million
Q2 2019

Aug 07, 2019

SELL
$23.33 - $28.3 $982,379 - $1.19 Million
-42,108 Reduced 17.19%
202,903 $5.74 Million
Q1 2019

May 08, 2019

SELL
$14.93 - $25.1 $301,586 - $507,020
-20,200 Reduced 7.62%
245,011 $6 Million
Q4 2018

Feb 12, 2019

SELL
$12.68 - $19.01 $124,264 - $186,298
-9,800 Reduced 3.56%
265,211 $4.15 Million
Q3 2018

Nov 13, 2018

SELL
$13.1 - $16.35 $108,730 - $135,705
-8,300 Reduced 2.93%
275,011 $4.11 Million
Q2 2018

Aug 02, 2018

SELL
$13.65 - $18.7 $81,354 - $111,452
-5,960 Reduced 2.06%
283,311 $4.12 Million
Q1 2018

May 14, 2018

BUY
$14.85 - $24.3 $154,068 - $252,112
10,375 Added 3.72%
289,271 $4.6 Million
Q4 2017

Feb 09, 2018

BUY
$17.4 - $23.4 $321,900 - $432,900
18,500 Added 7.1%
278,896 $5.7 Million
Q3 2017

Nov 14, 2017

BUY
$15.5 - $19.15 $246,574 - $304,638
15,908 Added 6.51%
260,396 $4.64 Million
Q2 2017

Aug 14, 2017

BUY
N/A
244,488
244,488 $4.32 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.08B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.